Novartis scoops Top Employer award

Published: 4-Feb-2019
Recruitment

Novartis UK and its subsidiary, Sandoz, have been certified as ‘Top Employers’ of 2019 by Top Employers Institute

The Top Employers Institute has certified Novartis and its subsidiary Sandoz as top employers for the sixth and third consecutive year, respectively.

This year, in addition to the UK branch and headquarter branch in Germany, Sandoz has been recognised globally.

To qualify for this the company must have 20 or more countries in a company’s network achieving the local certification. Sandoz is now certified in 28.

Promoting its status as an employee friendly company, Novartis launched three new wellbeing initiatives, including ones to help employees affected by cancer and mental health problems.

David Pink, CEO of the Top Employers Institute, said: “These companies help enrich the world of work with their outstanding dedication to HR excellence and because of this, they are recognised as an employer of choice.”

The certification is based on annual, international research undertaken by the Top Employers Institute that recognizes leading employers around the world and their excellence in employee environment. Novartis is a healthcare company, with Sandoz focusing on pharmaceuticals and biosimilars.

  • Companies:
  • Novartis
See more

You may also like

Recruitment

Symonds to join Novartis as deputy cfo in September

Read more
Jonathan Symonds, currently managing director, Investment Banking, at Goldman Sachs will be joining Novartis on 1 September as deputy cfo and cfo designate, reporting to Raymund Breu, who will retire on 31 March, 2010, after 35 years of service to Novartis."Symonds\' financial expertise, broad industry experience and deep knowledge of the healthcare industry make him especially suited to take on the responsibilities of CFO," said Dr Daniel Vasella, chairman and ceo of Novartis.Symonds spent eight years as cfo at AstraZeneca, where his position encompassed finance, M&A, strategy, IT, purchasing, business development and licencing. Before that he was finance director at Zeneca and a partner at KPMG.

Trending Articles

  1. Siemens Industrial business appoints Finance Director
  2. Change in the executive management team of Gerhard Schubert GmbH Gerald Schubert hands over responsibility to Marcel Kiessling
  3. A cure for gender diversity stalling in pharma The cure for pharma to stop gender diversity stalling is to appoint more women in P&L roles finds The Pipeline report
  4. Tetra Bio-Pharma appoints Gregory Drohan to board
  5. New director for the MRC Laboratory of Molecular Biology

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

You may also like

Recruitment

Symonds to join Novartis as deputy cfo in September

<p><strong>Jonathan Symonds</strong>, currently managing director, Investment Banking, at Goldman Sachs will be joining <em>Novartis</em> on 1 September as deputy cfo and cfo designate, reporting to Raymund Breu, who will retire on 31 March, 2010, after 35 years of service to Novartis.</p><p>&quot;Symonds\' financial expertise, broad industry experience and deep knowledge of the healthcare industry make him especially suited to take on the responsibilities of CFO,&quot; said Dr Daniel Vasella, chairman and ceo of Novartis.</p><p>Symonds spent eight years as cfo at AstraZeneca, where his position encompassed finance, M&A, strategy, IT, purchasing, business development and licencing. Before that he was finance director at Zeneca and a partner at KPMG.</p>
Recruitment

Rentschler Biopharma continues hiring at global sites

During 2021, the company has hired more than 300 employees across all business functions with a strong focus on production and laboratory personnel
Recruitment

Vetter Pharma invests $4.1m in Ravensburg training facility

The centre opened on September 14, with a small celebration held for management, training management and trainees.
Recruitment

Does pharma have a problem with inclusivity and innovation?

As we’ve seen only too clearly in recent weeks, the pharmaceutical industry is of paramount importance to the global economy and society. The collaboration regarding the COVID-19 pandemic is an example of the sector at its best, reports Stephen Frost, Founder, Frost Included
Recruitment

Cell Mogrify undergoes period of change

A cash injection and change in leadership gives momentum to the cell therapy company for direct cellular conversion platform
Recruitment

Retention, not just recruitment

Six ways to protect your company from the skills crisis
Recruitment

Particle Testing Authority (PTA) boosts company's thermal analysis capabilities

Particle Testing Authority (PTA), a division of Micromeritics Instrument Corporation, now has expanded thermal analysis capabilities with addition of Bryan Shaw to its team
Subscribe now